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Abstract Thunderclap headache attributed to reversible
cerebral vasoconstriction (THARCV) is a syndrome
observed in a number of reported cases. In this article we
reviewed this new headache entity (idiopathic form) using
the clinical-radiological findings of 25 reported patients. In
this series of patients 72% were women, the mean age at the
onset of first headache episode was 39.4 ± 2.3 years. In
addition to the sine qua non condition of being abrupt and
severe (thunderclap) at the onset, the headache was usually
described as being explosive, excruciating, or crushing. The
feature of pulsatility, accompanied or not by nausea was
described by 80% of the patients. Forty percent of the cases
manifested vomiting and 24% photophobia. Usually the
headache was generalized, and in three cases it was unilateral
at least at the onset. In 21 of 25 patients (84%) there was at
least one recurrence or a sudden increase in the intensity of
the headache. A past history of migraine was present in 52%
of the patients. Precipitating factors were identified in 56% of
the patients. Sexual intercourse was described by six
patients. Of the 25 patients with THARCV syndrome stud-
ied, 12 (48%) developed focal neurological signs, transitory
ischemic attack (n = 1), or ischemic stroke (n = 11, 44%),
and two (8%) of them manifested seizures. The THARCV
syndrome is a neurological disturbance perhaps more fre-
quent than expected, preferentially affecting middle aged
female migraineurs, and having an unpredictable prognosis,
either showing a benign course or leading to stroke.
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Introduction
Thunderclap headache attributed to reversible cerebral
vasoconstriction (THARCV) is a clinical-radiological
entity observed in a number of cases reported since 1978
[1]. The THARCV syndrome may include several of the
patients experiencing thunderclap headache [2–8], head-
ache associated with sexual activity [2, 8–12], isolated
benign cerebral vasculitis [13, 14], or migranous vaso-
spasm or stroke [15–17].
It is widely accepted that the aura of a migraine crisis
is associated with a vasoconstriction or vasospasm in the
arterial territory of the aura-related cerebral cortex, which
seems to be correlated with spreading depression, olige-
mia, or both [18–21]. In rare situations this arterial
constriction is severe enough to cause brain ischemia
[15–17]. Other conditions may induce much longer and
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intense cerebral artery narrowing [22–44], such as: sub-
arachnoid hemorrhage (SAH; largely the leading cause of
cerebral vasospasm) [22], drug abuse or sympathomimetic
drug administration (methamphetamine, heroin, ephed-
rine, and cocaine) [23–25], intracranial surgical manipu-
lation [26], head injury [27], herpes zoster [28],
pheochromocytoma [29], eclampsia [30], ergot derivatives
[31], angiographic contrast material [32], Lyme disease
[33], systemic lupus erythematosus (SLE), periarteritis
nodosa, primary granulomatous angiitis of the central
nervous system (GACNS), and other types of cerebral
arteritis [34–36]. Some of these disorders may course with
headache as well.
Intracranial aneurysm rupture is a relative frequent event
(&10/100,000/year) and it is very important to identify
those high-intensity headaches of abrupt onset mimicking
that of ruptured cerebral aneurysm. Primary thunderclap
headache (4.6) and reversible cerebral vasoconstriction
syndrome (6.7.3) are two clinical entities that may simulate
a headache associated with subarachnoid hemorrhage [45].
The combination of both—thunderclap headache and
reversible cerebral vasoconstriction—is being increasingly
identified in a number of patients assisted in the emergency
unit [44].
According to the IHS 2004 classification [45], the
diagnostic criteria of primary thunderclap headache are the
following: (A) severe headache fulfilling criteria B and C;
(B) Both of the following characteristics: (1) sudden onset,
reaching maximum intensity in \1 min; (2) lasting from
1 h to 10 days; (C) irregular occurrence over subsequent
weeks or months and (D) not attributed to another disorder.
The headache may recur within the first week after onset
and a normal cerebrospinal fluid (CSF) and normal brain
imaging are required.
On the other hand, the IHS 2004 criteria for headache
attributed to benign (or reversible) angiopathy of the cen-
tral nervous system are: (A) diffuse, severe headache of
abrupt or progressive onset, with or without focal neuro-
logical deficits and/or seizures and fulfilling criteria C and
D; (B) ‘‘strings and beads’’ appearance on angiography and
subarachnoid hemorrhage ruled out by appropriate inves-
tigations; (C) one or both of the following: (1) headache
develops simultaneously with neurological deficits and/or
seizures, (2) headache leads to angiography and discovery
of ‘‘strings and beads’’ appearance, (D) headache (and
neurologic deficits, if present) resolves spontaneously
within 2 months [45].
In the present article, we review the concept of this new
headache syndrome (i.e., THARCV) using the clinical-
radiological findings of 25 patients. Considering the man-
agement of patients with the THARCV syndrome, we shall
discuss the diagnostic criteria and the differential
diagnosis.
Review of reported patients
A MedlineTM search was performed using the English
keywords: thunderclap headache, explosive headache,
sudden headache, headache and vasospasm. Patients with a
clear history of thunderclap headache and angiograph
confirmation of cerebral vasoconstriction were selected to
be studied as a group.
In order to achieve a more uniform diagnosis of the
THARCV syndrome we propose the diagnostic criteria
listed in Tables 1 and 2. Since we consider the THARCV
as a secondary form of headache attributed to the reversible
cerebral segmental vasoconstriction it is further divided
into (I) idiopathic, or (II) symptomatic headaches.
The medical literature until 2003 was reviewed, and 25
reported cases of patients (Table 3), including the one
described by our own group, were selected according to the
proposed diagnostic criteria for idiopathic THARCV syn-
drome (Table 2). Although several other cases were
published in the recent years, we believe those 25 indi-
viduals represent a sample of the increasing number of
THARCV cases described in the literature.
Analysis of the data shown in the Table 3 shows a
profile of this particular headache subtype. In this series of
patients, 72% were women, the mean age at the onset of
first headache was 39.4 ± 2.3 years, ranging from 19 to
62 years (women, 26–62 years of age, mean 41.4 ± 2.7,
median 38.5; men, 19–49 years of age, mean 34.1 ± 4.2,
median 31.0). No significant difference in age was
observed between women and men (Student t-test;
P = 0.1665). Eight percent of the patients were 16–
25 years of age, 28% 26–35 years of age, 32% 36–45 years
of age, 24% 46–55 years of age, and 8% 56–65 years of
age.
The characteristics of the headache described, in addi-
tion to the sine qua non condition of being abrupt and
severe at the onset, differed according to patient descrip-
tion. The duration of the headache attack ranged from a
short period of time, i.e., 10–15 min, to as much as 3–
4 weeks (Table 4). In approximately half of the cases the
headache persisted up to 3 days. In one-third of the patients
the pain continued for a few hours (less than 24 h). The
Table 1 Proposed classification of reversible cerebral vasoconstric-
tion syndrome as idiopathic or symptomatic
I Idiopathic
II Symptomatic
IIa Associated with intracranial abnormalities other than cerebral
vasoconstriction (i.e., aneurysm, vascular malformation, brain
tumor, hemorrhage, venous thrombosis, etc.)
IIb Associated with systemic diseases
IIc Associated with use of vasoactive drugs
IId Associated with pregnancy
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quality of being explosive, excruciating, pounding, or
crushing was registered. Other headache features were
reported, such as throbbing, pulsatility, or pounding (68%),
being accompanied by nausea (44%), vomiting (40%), and
photophobia (24%). Furthermore, some of the patients
manifested blurred vision (8%). The headache was
described usually as generalized (32%) and bilateral; in
three cases it was unilateral at least at the onset.
In 21 of the 25 patients (84%) there was at least one
recurrence or a sudden increase in headache intensity. Three
or more recurrences were observed in five individuals
(Table 4). The time interval between the first headache and
recurrent attacks varied from a few hours up to 3 years. In 15
of 21 patients, recurrence was observed within the first week,
and in one patient five such recurrences took place within this
short period of time. In seven patients, recurrence was
observed on the first day after the onset of headache. In three
it occurred from 8 to 30 days. Two patients presented several
headache recurrences within a 2–4 year-period.
A past history of headache was present in 15 of the 25
reported cases (Table 4), including migraine in 13 patients
(52%), at least four of them with aura, one associated with
hormonal contraceptives and another after headaches that
had begun 8 years before during the first trimester of
pregnancy.
Precipitating factors were identified by 14 patients
(56%; Table 5), with sexual intercourse being the major
precipitating factor, reported by six patients (24%). Of the
25 patients with THARCV syndrome studied, 12 (48%)
developed focal neurological signs, transitory ischemic
attack (n = 1), or ischemic stroke (n = 11, 44%), and two
(8%) of them manifested seizures. Two other patients
presented seizures that were not related to stroke. Stiffness
of the neck was observed in one patient.
Probably cerebral artery narrowing was present for
several days after the onset of headache. In the different
reports vasoconstriction was diagnosed by arteriography
between two days and three weeks after the onset of
headache in 18 of the reported cases. Even though the
cerebral vasoconstriction was confirmed by angiography in
all 25 patients, in the other seven cases the interval
between the headache and the observed vasoconstriction
was not informed. In seven patients a control angiography,
performed 3–24 weeks later, was normal. In seven other
patients a second angiography performed 2–32 weeks later
demonstrated that most of the previously identified focal
narrowing had resolved. In one case (patient # 8 in
Table 3) an arteriography done 16 days later still demon-
strated diffuse arterial narrowing. In another patient (# 9 in
Table 3) an arteriography was repeated 15 days later
showing normalization of the previously stenotic left
internal carotid, but disclosing another arterial narrowing
in the right internal carotid. Any of the intracranial major
arteries can be affected; in one subject (patient # 2 in
Table 3) the external carotid artery was examined, dis-
closing involvement of the superficial temporal artery in
addition to the presence of intracranial artery narrowing.
No drastic abnormalities were observed in the CSF of
patient with THARCV syndrome, with the exception of an
eventual increase in protein levels.
Discussion
In this article we described the clinical and radiological
features of 25 reported cases of patients with a neurological
syndrome characterized by THARCV.
The management of patients with the THARCV
syndrome can be subdivided into pathophysiology deter-
mination and diagnostic and therapeutic strategies.
Diagnosis and initial management
The headache of the THARCV syndrome typically is of
acute onset and increases abruptly in severity, reaching
Table 2 Proposed diagnostic criteria for thunderclap headache attributed to idiopathic reversible cerebral vasoconstriction (THARCV)
syndrome
A. At least one headache attack with the following characteristics
1. Abrupt and explosive headache
2. Severe
B. Presence of reversible intracranial arterial narrowing
C. No association with conditions such as
1. Vascular malformation, aneurysm, subarachnoid hemorrhage, CNS vasculitis or trauma
2. Pheochromocytoma, systemic vasculitis
3. Use of illicit drugs or other known vasoactive (constrictor) substances
4. Pregnancy, post-partum or eclampsia
Obs.: the following characteristics when present strongly suggest THARCV syndrome: (a) female sex, (b) pulsating quality, (c) recurrence of
headache, (d) precipitation or aggravation of the headache attack by physical or sexual activities, and (e) past history of migraine
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peak severity in less than 60 s (thunderclap headache) [46].
The pain can be precipitated or aggravated by physical or
sexual activities. The duration of the headache can be
5 min or longer. Thus, we propose some minor changes in
the thunderclap diagnostic criteria modified by Dodick
et al. [2]: (a) time to reach peak severity up to 60 s; (b)
headache duration of 5 min or longer, since the explosive
type of headache occurring during sexual activity is con-
sidered to be a thunderclap headache [46] and may be of
short duration. Even though the International Classification
of Headache Disorders, 2nd edition (ICHD-II) criteria
stipulate that the pain of primary thunderclap headache last
from 1 h to 10 days (Code 4.6) [45].
We could subdivide the THARCV syndrome into idio-
pathic and symptomatic. The symptomatic THARCV
syndrome should fulfill the A and B items of the proposed
diagnostic criteria, and is categorized into four subgroups:
(IIa) associated with intracranial abnormality (vascular
malformation, aneurysm, subarachnoid hemorrhage, CNS
vasculitis or trauma); (IIb) associated with systemic disease
(e.g., pheochromocytoma or systemic vasculitis); (IIc)
associated with drug abuse and use of vasoactive drugs
(e.g., ergotamine, cocaine, heroin, methamphetamine,
ephedrine, tryptans, intravenous use of contrast sub-
stances); or (IId) associated with pregnancy, post-partum or
eclampsia. As exclusion criteria we consider the presence
of systemic vasculitis or a central nervous system (CNS)-
meningeal biopsy showing inflammatory features related to
CNS vasculitis.
More specifically, during the management of a patient
with a thunderclap headache, as a general rule a CT brain
scan without contrast is required. If a diagnosis is not made
by this CT, lumbar puncture and CSF examination is
mandatory during the acute phase to rule out any intra-
cranial symptomatic lesion, particularly SAH and its
causes. Both the CT scan and CSF are expected to be
normal, with the exception of patients with stroke, cerebral
Table 4 Duration, location, characteristic, number of occurrence of




\24 h 10 40
24 h–3 days 5 20
4 days–7 days 3 12










Abrupt onset 25 100
Severe intensity 25 100





Blurred vision 2 8
Dull ache 1 4
Excruciating 1 4
Crushing 1 4
Sense of spinning 1 4









Past history of headache 15/25 60
Migraine 13 52
With aura 4 16
Without aura 3 12
Unclassified 6 24
Tension-type headache 1 4
Associated with CCD 1 4
Associated with pregnancy 1 4
CCD contraceptive drug
a Some of the patients presented recurrent headaches of different
duration
Table 5 Precipitating factors identified in 14 of the 25 reported cases
of patients with THARCV syndrome
Precipitating factor n %




Exposure to cold 1 4
Total number of patients 14/25 56
a Activities defined as exertion were calisthenics (i.e., sit ups, push-
ups, and skipping rope), getting up from bed, straining, bending,
swimming, snorkeling, and chasing off and screaming at an attacking
dog
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edema, or intracranial hypertension, in which CSF abnor-
mality is the result of these complications. Conventional
cerebral angiography should be avoided, since the contrast
medium could enhance the vasospasm and this, in turn,
would increase the chance of a stroke or even cause the
deterioration of a previously critical neurological condi-
tion, particularly in migraineurs [16, 47]. The next step
would be the request of a good-quality magnetic resonance
(MR) angiography or angio-computed tomography (CT) of
intracranial vessels as soon as possible, in such a way that
any moderate to severe (reversible) vasoconstriction would
be visualized. The conventional arteriography should be
performed later, 3–4 weeks after the last severe headache
attack. During the arteriography a study of the external
carotid artery and its branches should be included in an
attempt to find a segmental narrowing in a superficial
artery. This could allow an easier (extracranial) approach
to an eventual vessel biopsy.
Patients with thunderclap headache in the absence of
cerebral vasospasm have been reported [48, 49]. This
probably is factual, but the possibility of a short-lived
cerebral arterial spasm occurring only at the onset of or
during headache still needs to be excluded. Rothrock et al.
[16] discussed why delayed arteriography would miss a
transient spasm/stenosis to confirm migrainous stroke, to
justify the lack of abnormality found in angiograms of
patients who developed stroke during a migraine attack.
Differential diagnosis
The idiopathic THARCV syndrome is a disease with
cerebral vasoconstriction. Hence, all the other possibilities
that could provoke an intracranial arterial narrowing should
be taken into account. The lack of systemic features
enhances the possibility of a given arterial luminal nar-
rowing to be part of the more benign THARCV syndrome
when compared with CNS vasculitis, in which no resolu-
tion of the vascular disease is expected without adequate
treatment. Although reversibility of intracranial arterial
narrowing is anticipated in the THARCV syndrome it may
take weeks to happen. Even though the reversibility of the
vasoconstriction is not important during the initial diag-
nostic criteria, the reversibility of the condition needs to be
proved, as the syndrome is called reversible. Since this has
not always been made in previous studies as well as in IHS
2004 classification [45], the confirmation of the revers-
ibility of the vasoconstriction should be included in the
final diagnostic criteria, thanks to the reliability of less
expensive or invasive techniques (e.g., angio-RM or angio-
CT).
In the discussion of some of the particularities that
should differentiate the THARCV syndrome from other
identified causes of arterial narrowing we may mention
some features, particularly those concerning CNS vascu-
litis [37], a rare inflammatory disease of vessel walls
associated with many causes (i.e., infection, malignancy,
ionizing radiation, drug abuse, and autoimmune disease).
Since angiographic features in cerebral arteritis are not
completely specific, the associated radiologic and clinical
findings often are fundamental elements for a diagnosis
[34]. Narrowing of a vessel may be the result of spasm,
edema, cellular infiltration, or proliferation of the vessel
wall as well as compression by adjacent thickened
meninges, exudates, or fibrosis [34].
Cerebral arterial narrowing might be subdivided into
four groups: (1) vasospasm (contraction of arterial smooth
muscle); (2) thickening of the vessel wall; (3) extrinsic
compression; and (4) developmental or congenital [40].
Very probably the THARCV is a form of headache
attributed to reversible cerebral vasoconstriction syndrome
(benign or reversible angiopathy of the CNS, ICHD-II
Code 6.7.3) [39, 45].
According to the IHS 2004 criteria for headache
attributed to benign (or reversible) angiopathy of the
central nervous system, a severe headache of progressive
onset occurring during the clinical presentation of the
syndrome is permitted [45]. In the present article we intend
to study the thunderclap headache attributed to reversible
cerebral vasoconstriction syndrome. Furthermore, we do
not agree with the IHS D criterion [45]: ‘‘Headache (and
neurological deficits, if present) resolves spontaneously
within 2 months’’. It is well known that an ischemic stroke
may course with permanent neurological deficit.
Mechanical, biochemical, or neurogenic causes may
explain the arterial spasm. Vasoactive substances may
cause vasospasm, such as chemical substances (ergota-
mine, amphetamine, cocaine), metabolite substances (in
eclampsia or pheochromocytoma), and toxins (angio-
graphic contrast material) [40].
In the group of autoimmune mediated diseases we may
mention primary GACNS, SLE, polyarteritis nodosa, giant
cell arteritis, and Sjo¨gren syndrome. The physician should
also search for other conditions that are known to cause
vasculitis, such as drug hypersensitivity, cancer, infection,
rheumatoid arthritis, and inflammatory bowel disease [36].
Noninfectious vasculitides can be classified on basis of the
predominant type of vessel affected: large-vessel vasculitis
(giant-cell arteritis and Takayasu0s arteritis), medium-
sized-vessel vasculitis (polyarteritis nodosa, Kawasaki0s
disease, and primary GACNS vasculitis), and small-vessel
vasculitis (ANCA-associated small-vessel vasculitis,
immune-complex small-vessel vasculitis, paraneoplastic
small-vessel vasculitis, and inflammatory bowel disease
vasculitis) [36]. Infectious arteritis includes bacterial,
tuberculous, fungal, yeast, luetic (meningovascular
J Headache Pain (2008) 9:277–288 283
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syphilis), cysticercosis, rickettsia, and viral disorders [34].
Sarcoidosis and chemical and radiation arteritis should also
be kept in mind.
Primary granulomatous angiitis of the CNS is a pro-
cess usually restricted to vessels of B0.5 mm diameter,
an arteriopathy that frequently is not visualized by
angiography. But this inflammatory disorder may also
involve large cerebral vessels [37]. The diagnosis of
isolated angiitis of the CNS should be taken into con-
sideration if the patient is young, presenting focal
neurological signs, seizures, or constant severe headache.
Without treatment (i.e., glucocorticoid) the clinical
course of the GACNS, as may be expected, is often
progressive. To establish a definitive diagnosis a lepto-
meningeal biopsy is necessary [14, 50]. To decide which
patients are candidates for biopsy it does depend on the
gravity of the neurological picture, the functional
importance of the cerebral artery to be biopsied, and lack
of response to corticoid therapy.
Similar segmental narrowing was also reported in
atypical cluster headache involving proximal portions of
the middle and anterior cerebral arteries [51]. Additionally,
hyperventilation induced by pain might cause vasocon-
striction as well [52].
Several cases of women with preeclampsia-eclampsia
and a history of sudden, severe headache accompanied by
cerebral artery narrowing have been reported previously
[30, 39, 53]. Preeclampsia is a frequent disorder charac-
terized by hypertension, abnormal peripheral edema, and
proteinuria. Most of the patients experience neurological
signs and symptoms, such as headache, visual changes,
confusion, disturbances of consciousness, or seizures. Such
manifestations of the disease are identical to those of
hypertensive encephalopathy. Clinical and radiographic
signs of hypertensive encephalopathy probably are related
to the consequences of an acute increase in systemic blood
pressure, which, in turn, would affect the autoregulation of
the cerebral vasculature.
Call et al. [39] reported four patients with reversible
cerebral segmental vasoconstriction and concluded that
their cases may represent a severe ‘‘clustering’’ form of
migraine. These authors identified 12 other cases reported
in the literature with clinical and angiographic similarities
to their four cases, six occurring in the postpartum period,
five being idiopathic, and one associated with an unrup-
tured aneurysm. The cited authors also commented that the
clinical feature of presentation resembles the rupture of an
intracranial aneurysm, with a sudden, high-intensity head-
ache associated with nausea, vomiting, and photophobia. In
six cases biopsy or autopsy of one vasoconstricted artery
disclosed no anatomic abnormalities.
On the other hand, the occurrence of vascular abnor-
mality (narrowing) in young women and during the
postpartum period, strongly suggests a hormonal influence
exerted by sex steroids [39].
Cerebral postpartum angiopathy was described by Ras-
col et al. [54] in four women with distal arterial occlusion.
None of them had arterial hypertension or renal disease.
Hansen et al. [55] evaluated the effect of preeclampsia on
cerebral artery blood flow velocity and concluded that
cerebral vasospasm of the smaller diameter vessels is a
major component of preeclampsia. Trommer et al. [30]
reported that eclampsia might cause spasm of large- and
medium-caliber cerebral vessels. They described the case
of a 27-year-old woman, who 15 min postpartum com-
plained of headache, nauseas, and epigastric pain and
whose cerebral angiogram showed diffuse spasm.
Henry et al. [31] reported the case of a 34-year-old
woman that during delivery, 10 min after receiving an
intravenous administration of methylergometrine, experi-
enced violent headache, associated with vomiting and
arterial blood hypertension. Hours later the patients suf-
fered seizures and mental confusion, with evolution to
coma. An arteriography revealed marked segmental nar-
rowing of the first middle cerebral artery branch. The
authors postulated that the ergot-derived drug caused
vasoconstriction through noradrenergic and serotoninergic
actions. This class of drugs is particularly used during
labor. Additionally, bromocriptine for lactation suppression
in combination with a sympathomimetic agent caused
hypertension, severe headache, seizures and cerebral
vasospasm in a patient during the puerperium [56]. These
facts may indicate that, during delivery or the postpartum
period, patients are more susceptible to administration of
vasoactive drugs and this, in turn, can precipitate arterial
spasm.
Sudden surges in blood pressure may trigger a cerebral
vasospasm, as also observed after adrenergic stimulation
by the use of cocaine [25], by pheochromocytoma [29], or
eclampsia [30]. Kaye and Fainatat [25] described the case
of a cocaine addict, a 22-year-man, who developed right-
sided headache associated with transient blurring of his
vision. Four days later he presented weakness of the left
side, and an arteriogram performed 5 days after the onset of
the hemiparesis demonstrated the presence of narrowing of
the supraclinoid portion of the right internal carotid and the
occlusion of the proximal segment of the middle cerebral
artery.
Patients with pheochromocytoma usually experience
bilateral paroxystic episodes of bifrontal headache, radiat-
ing to temporal regions or secondarily generalizing,
described as pulsating, moderate to severe in intensity.
Lying down, moving, coughing, or straining makes the
headache worse [57]. The above-mentioned features are
similar to the headache described by patients with
THARCV syndrome, which may suggest that sudden
284 J Headache Pain (2008) 9:277–288
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increases in arterial blood pressure in the presence of a
cerebral arterial narrowing may trigger a headache attack
[8].
Serdaru et al. [13] stated that during a migraine attack
narrowing of the internal carotid artery usually involves
either its extradural [18] or intracavernous [58] portion.
Pathophysiology
Two important questions should be answered: ‘‘What are
the precipitants of vasoconstriction?’’ and ‘‘Is vasocon-
striction the cause of pain?’’ Considering the vasospasm
due to SAH and the biology of blood vessels, we could
speculate about the pathophysiology of the supposed
vasospasm found in THARCV syndrome.
The smooth muscle cell contraction occurring during
SAH is still poorly understood. Vascular caliber may
reflect adrenergic tone and sympathetic receptor sensitivity.
Several factors participate in the regulation of vascular
tone. The regulation of cerebral blood flow (CBF) is a fast
and selective phenomenon and dramatic changes in blood
flow or volume can be induced within a short period of
time (seconds or minutes) regarding specific or regional
brain areas either in normal [59] or abnormal (e.g., epi-
lepsy) [60] physiologic conditions. The oscillations present
in intracranial pressure are secondary to spontaneous
changes in CBF velocity as a result of rhythmic changes in
cerebral vessel diameter triggered by monoaminergic and
serotonergic centers present in the brainstem [61].
In addition, arterial constriction followed by dilatation is
postulated to be part of the pathophysiology mechanism
of migraine [18]. The vascular endothelium synthesizes
vasorelaxant substances, e.g., endothelium-derived relaxing
factor (EDRF), acetylcholine (ACh), bradykinin, purines
(i.e., ATP), histamine, vasopressin, substance P, neurokinin
A and B, and prostaglandin F2a. On the contrary, endo-
thelium-derived constricting factors may also be involved
in the control of vascular tone, including serotonin, nor-
epinephrine (NE), prostaglandin E2, thromboxane A2,
leukotriene C4, endothelin (ET)-1, and ET-3. In addition,
ACh releases EDRF. NE also induces release of EDRF and
substance P, which seem to attenuate the vasoconstrictor
response to NE. EDRF was identified as being nitric oxide
(NO), which is produced by neurons, glia, and endothelium.
Sympathetic nerve varicosities release NE and other puta-
tive transmitters such as ATP, neuropeptide Y (constrictor),
vasoactive intestinal peptide (dilators), and calcitonin
gene-related peptide (dilator) [62].
Blood-borne NE and stimulation of sympathetic nerves
do not affect significantly brain circulation [63]. After
chronic trigeminal ganglionectomy there was an increase in
the constrictor response of pial arteries to NE [64]. Also,
inhibition of EDRF synthesis of or endothelial denudation
enhances the vasoconstriction induced by NE. Likewise,
acute hypertension allows the occurrence of important
vasoconstrictor effects induced by sympathetic stimulation
[65], indicating that, under certain circumstances, cerebral
vessels may respond to noradrenergic stimuli. Interestingly,
acute hypertension generates superoxide anion, which, in
turn, inactivates EDRF [66]. This may reverse the ACh-
induced cerebral arterial dilatation and augment cerebral
vasoconstriction induced by NE, or sympathetic
stimulation.
High levels of vasoactive and spasmogenic substances
are present in the CSF and plasma of patients with SAH
and vasospasm [22]. In the presence of SAH, endothelium-
dependent relaxation is impaired by the production of
potent endothelium-derived contracting factors (cyclooxy-
genase products of arachnoid acid and ET). Endothelin, a
21 amino acids peptide, has very potent and long-lasting
constrictive effects. Many lines of evidence suggest that ET
may be intimately involved in the genesis of the cerebral
vasospasm. The plasma concentration of ET-1 is higher in
patients with vasospasm than in patients without symp-
tomatic vasospasm, with the peak concentration coinciding
with the occurrence of the vasospasm. In isolated human
cerebral artery segments, ET produced intense and sus-
tained vascular constriction, which was inhibited by
sodium nitroprusside or verapamil. The enhanced vascular
tone induced by ET is resistant to NE antagonists, seroto-
nin, isoproterenol, histamine, ACh, and angiotensin II. In
canine basilar artery, calcium-channel blockers such as
nicardipine and papaverine reversed the contraction
induced by ET-1. The arterial contraction induced by both
NE and serotonin is amplified by the addition of low
concentrations of ET-1 [22]. During experimental SAH the
cerebral vessels are hyperreactive to ET, indicating that in
a given situation of higher reactivity of a particular seg-
ment of the cerebral arterial system (by a reason not yet
known) sudden release of NE, serotonin, or any other
vasoconstrictor into the circulation could precipitate a
severe and long-lasting segmental arterial constriction. Or
yet again, the lack of action of endogenous substances with
vasodilator properties would facilitate vasoconstriction.
Nitric oxide also inhibits ET-1 synthesis. A close
interaction between ET (a vasoconstrictor) and NO (a
vasodilator) appears to take place and to play a major
physiologic role in the control of CBF and vessel caliber.
So, any disturbance that may occur in the equilibrium
between constrictor and dilator factors could generate
arterial spasm.
Endothelin-1 levels increase during [67–69] and
between migraine attacks [67], suggesting that the peptide
is implicated in the physiopathogenesis of migraine. It was
reported that a variant of the ETa receptor gene modulates
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the risk for migraine [70]. This may imply that migraineurs
with qualitatively or quantitatively altered ETa receptor
may present dysregulation of arterial tone, resulting in
inadequate dilatation or constriction of cerebral vessels in
response to different stimuli.
Supporting the hypothesis that NO might also participate
in the genesis of pain, nitroglycerin, by provoking vasodi-
latation via NO formation, is able to induce in healthy
subjects an immediate, short-lasting, bilateral fronto-tem-
poral and pulsating headache, that can be aggravated by
routine physical activity [71]. Intriguingly, nitroglycerin
causes a more severe pain in migraine patients [72, 73].
Alteration of intracranial vessel tone and regional instability
of the CBF were documented in migrainous patients during
the headache-free interval [74–77]. This suggests that
cerebral arteries of migraineurs might react differently to
diverse stimuli. If so, this fact may justify the frequent
occurrence of the syndrome in migranous subjects.
Buckele et al. [78] described the case of a 16-year-old
girl experiencing an attack associated with headache, when
she suddenly felt tired and faint (not well characterized if it
was abrupt or severe) that was repeated several times within
a period of four months. Such attacks were thought to be the
expression of migraine events, in view of the slow progress
of some episodes, accompanied by fatigue, drowsiness, and
cold hands. An arteriogram revealed widespread intense
intracranial vasospasm. The clinical course progressed to
death due to intracranial hypertension and cerebral edema.
No evidence of primary vascular disease was found at
autopsy. This case led to the assumption that the THARCV
syndrome may eventually course with atypical headache
episodes or even without any pain at all, including a number
of young adult patients with stroke. Most but not all the
headaches associated with reversible cerebral vasocon-
striction have the characteristics of thunderclap headache
according to most recent findings [79]. Such reported cases
were not included in our analyzed series to study better the
profile of typical patients with THARCV syndrome.
Dr. Robert H. Ackerman [37] commented about the
multiple areas of narrowing, beading, and sausage-shaped
dilation of cerebral vessels observed during angiography of
patient # 3 in Table 3 as follows: ‘‘These segmental
changes are nonspecific signs that can be found in a
number of primary and secondary disorders affecting the
pial vessels, which lie in the subarachnoid space and
receive an investiture of pia as they enter the brain.’’ These
data suggest the possibility of a local relationship between
CSF, arterial vessels, and brain parenchyma to explain
segmental vasospasm.
Interestingly, the pattern of the cerebral arterial spasm
generated by a number of different etiologic causes has the
particular feature of being segmental in nature. In addition,
it is a short lasting (hours or days), reversible phenomenon.
This may suggest that the constriction of a major cerebral
artery is segmental and does not involve the entire exten-
sion of the vessel, particularly during high-intensity
stimulation. Are those localized vascular constrictions
observed in intracranial arteries during the conditions dis-
cussed above anatomic-functional sphincters controlling
local blood flow? Or is the vasospasm occurring in the
THARCV syndrome primarily a sphincter disturbance?
Precipitating factors, such as sexual activity, may induce
vascular changes with profound hemodynamic fluctuations,
which may trigger the pain if an arterial narrowing is present.
In this regard, during continuous monitoring of intra-arterial
blood pressure Mann et al. [80] documented that during
coitus, peaks values of up to 300/175 mmHg were registered,
with a mean of 237/138 mmHg for men and of 216/
127 mmHg for women, in hypertensive subjects.
Tricyclic antidepressants (i.e., amitriptyline), potent
inhibitors of the neuronal uptake of NE, systemically
administered to humans caused a reduction of the whole
body NE spillover to plasma, due to the reduction in nerve
firing rates. Propranolol had a similar effect on NE over-
flow [81]. Propranolol, by blocking vascular b-receptors,
could impair the anticipated vasodilatation induced by
activating b-adrenergic receptors. So, propranolol could
facilitate a predominance of the vasoconstrictor effect.
Nonselective beta-blockers can also have the adverse effect
of increasing platelet aggregability. In this regard, the
association of propranolol with stroke in migraineurs has
been mentioned previously [82, 83]. Lance and Goadsby
[84] advise to avoid the use of beta-blockers in migraineurs
with prolonged aura or severe focal neurological symp-
toms. In this respect, three of the patients presented in
Table 3 (# 4, 12, and 21) were under prophylactic use of
propranolol, and patient # 3 had aggravation of the neu-
rological manifestation after introduction of propranolol in
her prescription. Similar vascular changes in reactivity to
endogenous substances can happen with the therapeutic use
of amitriptyline. By the way, two patients of the 11 cases
described as isolated angiitis of the CNS [14] were using
either propranolol (case 6) or tricyclics (case 9). Do these
pharmacological substances facilitate the development of
cerebral vasospasm? This question remains to be answered.
The diagnosis of a growing number of patients with the
THARCV syndrome is anticipated nowadays, mainly with
the broad use of the harmless CT or MR angiography and a
greater knowledge of the syndrome. This study was pre-
viously presented at the Brazilian Headache Congress in
2002 [85] as a new headache syndrome named ‘‘Abrupt
severe headache associated with segmental artery narrow-
ing (ASHCAN)’’ [8, 86] and since then several other cases
of the syndrome have been reported [44, 79, 87–89].
In conclusion, the present article was written in an
attempt to better characterize the profile of the patients
286 J Headache Pain (2008) 9:277–288
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with THARCV syndrome. This syndrome is a neurological
disturbance; perhaps more frequent than expected, prefer-
entially affecting migrainous middle-aged women, with an
unpredictable prognosis, either having a benign course or
leading to stroke.
Conflict of interest None.
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